About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis

NCT00796809·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Arizona

With

Centocor, Inc.

Retrospective chart review of all patients with an inflammatory arthritis seen at the University Rheumatology clinic since January 2000.

Age

Any age

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

All active patients with an inflammatory arthritis seen at the University of Arizona from January 2000

You may not be if

None

The record

StatusCompleted

PhaseNo phase

Taking part598

StartedOct 2007

UpdatedDec 14, 2015

Conditions

Coccidioidomycosis Rheumatoid Arthritis

Where1

University of Arizona - Arizona Arthritis Center
Tucson, Arizona, United States